Crypto News

2 days ago

Immutep (IMMP) Stock Plummets 80% Following Phase III Lung Cancer Study Termination

Stocks

Immutep (IMMP) stock plummeted 80% after the company halted its Phase III NSCLC trial for futility, triggering analyst downgrades and massive selling.

The post Immutep (IMMP) Stock Plummets 80% Following Phase III Lung Cancer Study Termination appeared first on Blockonomi.

Source: Blockonomi →

Related News

Trending Category

$ADA$ARB$BITF$BLSH$BMNR$BONK$DBKSF$ENA$LUXFF$MATH$MTT token$NIGHT$PUMP$RAY$S$SEA$SOL$SPACE token$SPTZ$SPX

Latest News